← Back to Search

Behavioral Intervention

OUD intervention for Opioid Use Disorder

N/A
Recruiting
Led By Susan L Calcaterra, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up calculate mean monthly cows scores over a three year time frame (including pre and post implementation) to assess for change
Awards & highlights

Study Summary

"This trial introduced a new treatment program for opioid use disorder in 12 hospitals in Colorado to help adults with opioid use disorder who are hospitalized."

Who is the study for?
This trial is for hospitalized adults in Colorado who are diagnosed with Opioid Use Disorder (OUD) and are experiencing a gap in treatment. Specific eligibility criteria details were not provided, so it's important to contact the study organizers for more information.Check my eligibility
What is being tested?
The trial is testing an intervention designed to improve OUD treatment among hospitalized patients across 12 hospitals. It aims to address the current shortcomings in care for individuals suffering from opioid addiction.See study design
What are the potential side effects?
Since specific interventions and their side effects aren't detailed, potential participants should ask the research team about what treatments are involved and any associated risks or side effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change
This trial's timeline: 3 weeks for screening, Varies for treatment, and calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in buprenorphine prescribing at hospital discharge
Secondary outcome measures
Change in rates of methadone prescribing during hospitalization
Other outcome measures
Change in average (mean) COWS score over time
Change in naloxone prescribing at hospital discharge

Trial Design

1Treatment groups
Experimental Treatment
Group I: OUD interventionExperimental Treatment1 Intervention
Participants received education on the diagnosis and management of OUD, have access to protocols to walk them through assessment of OUD using Diagnostic and Statistical Manual, fifth Edition (DSM)-5, COWS score to calculate severity of opioid withdrawal, buprenorphine or methadone initiation with pre-populated orders, and clickable links for OUD treatment referral post discharge.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,752 Previous Clinical Trials
2,165,199 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,492 Previous Clinical Trials
2,622,656 Total Patients Enrolled
Susan L Calcaterra, MDPrincipal InvestigatorUniversity of Colorado, Denver
~171 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top